"Designing Growth Strategies is in our DNA"

U.S. Sexually Transmitted Disease Testing Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Kits), By Application (Chlamydia, Syphilis, Genital Herpes, Gonorrhea, Human Immunodeficiency Virus, Human Papillomavirus, and Others), By Setting (Laboratory Testing and Point-of-Care) By End User (Hospital & Clinics, Clinical Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108002

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Key Diseases, 2022
    2. Key Industry Developments: Mergers, Acquisitions & Partnerships
    3. New Product Launches, By Key Players
    4. Overview of Regulatory Scenario in the U.S.
    5. Technological Advancements in Sexually Transmitted Disease Testing Market
    6. Impact of COVID-19 on Global Sexually Transmitted Disease Testing Market
  5. U.S. Sexually Transmitted Disease Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of Care (POC)
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Abbott
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. BD
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Hologic, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. bioMerieux, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Cepheid (Danaher Corporation)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. DiaSorin S.p.A
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  U.S. Sexually Transmitted Disease Testing Market Revenue Breakdown (USD billion, %), By Product Type, 2022 & 2030

Figure 2:  U.S. Sexually Transmitted Disease Testing Market Value Share (%), By Product Type, 2022 & 2030

Figure 3:  U.S. Sexually Transmitted Disease Testing Market Value Share (%), By Application, 2022 & 2030

Figure 4:  U.S. Sexually Transmitted Disease Testing Market Value Share (%), By Setting, 2022 & 2030

Figure 5:  U.S. Sexually Transmitted Disease Testing Market Value Share (%), By End User, 2022 & 2030

Figure 6:  U.S. Sexually Transmitted Disease Testing Market Share (%), 2022

Table 1:  U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 2:  U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 3:  U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By Setting, 2019–2030

Table 4:  U.S. Sexually Transmitted Disease Testing Market Revenue (USD billion) Forecast, By End User, 2019–2030

 

U.S. Sexually Transmitted Disease Testing Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase